All content is for general information only — not medical advice, not a dosing or usage recommendation, and not a claim of efficacy. Many substances are not approved as medicines or are prescription-only; whether possession and use are legal depends on the law of your country of residence and is your own responsibility. myPeptides does not sell or supply any substances — it is an information and organization tool. For health questions, consult a licensed physician or pharmacist.

Peptide comparisons

Two substances side by side: how they work, what the studies show, their approval status in seven markets and where WADA stands. The status data comes from the peptide register. No doses, no suppliers, no efficacy claims.

Adamax vs SemaxAdamax vs Semax: differences, evidence and safetyAdamax vs Semax: an unstudied shop product against a peptide licensed in Russia. What each one is, what the records show, safety gaps and legal status.Read the comparison AHK-Cu vs GHK-CuAHK-Cu vs GHK-Cu: differences, evidence and safetyAHK-Cu vs GHK-Cu: how the two copper peptides differ, what the hair and skin studies found, and how their cosmetic, legal and anti-doping status compares.Read the comparison AOD-9604 vs TesamorelinAOD-9604 vs Tesamorelin: differences, evidence and safetyAOD-9604 vs tesamorelin compared: a growth hormone fragment that missed its trial targets and a US prescription medicine for belly fat in HIV.Read the comparison BPC-157: oral vs injectionBPC-157 oral vs injection: what the studies showBPC-157 oral vs injection: what animal studies and the few human reports show for each form, what is unknown about uptake, safety and doping status.Read the comparison BPC-157 vs TB-500BPC-157 vs TB-500: differences, evidence and safetyBPC-157 vs TB-500: how the two unapproved peptides differ, what the direct rat study found, what is known about combining them, safety and doping status.Read the comparison Cagrilintide vs RetatrutideCagrilintide vs Retatrutide: differences, evidence and safetyCagrilintide vs retatrutide: an amylin copy against a triple hormone agonist, both experimental. How they work, trial results, side effects and legal status.Read the comparison CJC-1295 DAC vs CJC-1295 (no DAC)CJC-1295 DAC vs no DAC: differences, evidence and safetyCJC-1295 DAC vs no DAC compared: one shared core, one albumin hook. Half-life, the human studies of the DAC form, the stopped trial, safety and legal status.Read the comparison Eloralintide vs CagrilintideEloralintide vs Cagrilintide: differences, evidence and safetyEloralintide vs cagrilintide: two experimental amylin copies from rival companies. Receptor profiles, trial results, side effects and legal status compared.Read the comparison Epitalon vs PinealonEpitalon vs Pinealon: differences, evidence and safetyEpitalon vs Pinealon: two short St Petersburg peptides, one named after a gland it does not come from. How they differ, what studies measured, safety, status.Read the comparison GHK-Cu: topical vs injectionGHK-Cu topical vs injection: what the studies showGHK-Cu on the skin vs by injection: what the cream trials and animal studies found, how much crosses skin, and the cosmetic and legal status of each form.Read the comparison GHRP-2 vs GHRP-6GHRP-2 vs GHRP-6: differences, evidence and safetyGHRP-2 vs GHRP-6 compared: two early ghrelin-receptor peptides, how they differ in hormone effects, appetite data, Japan’s diagnostic licence and safety.Read the comparison GLOW vs KLOWGLOW vs KLOW: differences, evidence and safetyGLOW vs KLOW: two peptide blends that differ only by KPV. What the four ingredients are, what their separate studies show, safety gaps and legal status.Read the comparison Ipamorelin vs SermorelinIpamorelin vs Sermorelin: differences, evidence and safetyIpamorelin vs sermorelin: two peptides that make the body release growth hormone through different receptors. Studies, safety and legal status compared.Read the comparison Ipamorelin vs TesamorelinIpamorelin vs Tesamorelin: differences, evidence and safetyIpamorelin vs tesamorelin: two peptides that make the body release growth hormone through different receptors. Studies, safety and legal status compared.Read the comparison Kisspeptin-10 vs hCGKisspeptin vs hCG: differences, evidence and safetyKisspeptin vs hCG compared: where each acts in the hormone chain, what the studies measured, the safety record and the legal status in seven markets.Read the comparison Kisspeptin-10 vs PT-141Kisspeptin vs PT-141: differences, evidence and safetyKisspeptin vs PT-141 (bremelanotide): one acts on reproductive hormones and is approved nowhere, the other is a US medicine. How they work, trials, safety.Read the comparison Liraglutide vs SemaglutideLiraglutide vs Semaglutide: differences, evidence and safetyLiraglutide vs semaglutide: two approved GLP-1 medicines from one maker. How they differ, the only head-to-head trial found, side effects and legal status.Read the comparison Liraglutide vs TirzepatideLiraglutide vs Tirzepatide: differences, evidence and safetyLiraglutide vs tirzepatide: two approved prescription medicines, one acting on one gut hormone receptor, one on two. Trials, side effects and status compared.Read the comparison Mazdutide vs RetatrutideMazdutide vs Retatrutide: differences, evidence and safetyMazdutide vs retatrutide: a dual-acting drug licensed only in China against a triple-acting one approved nowhere. Trials, side effects and legal status.Read the comparison Mazdutide vs TirzepatideMazdutide vs Tirzepatide: differences, evidence and safetyMazdutide vs tirzepatide: a drug licensed only in China against one approved in eight markets. Hormone targets, trial results, side effects and legal status.Read the comparison Melanotan I vs Melanotan IIMelanotan 1 vs Melanotan 2: differences, evidence and safetyMelanotan 1 vs Melanotan 2: one is an approved implant for a rare light disease, the other is approved nowhere. Mechanism, studies, case reports, legal status.Read the comparison MOTS-c vs NAD+MOTS-c vs NAD+: differences, evidence and safetyMOTS-c vs NAD+: how the mitochondrial peptide and the coenzyme differ, what mouse and human studies found, what is known about safety and the sport rules.Read the comparison PT-141: nasal spray vs injectionPT-141 nasal spray vs injection: what the studies showPT-141 nasal spray vs injection: the nasal form was dropped before phase 3, the injection is approved in the US. Trials, kinetics, safety and legal status.Read the comparison Semax vs SelankSemax vs Selank: differences, evidence and safetySemax vs Selank: two Russian nasal peptides from different parent molecules. How they differ, what the human studies measured, safety and legal status.Read the comparison Sermorelin vs Somatropin (HGH 191AA)Sermorelin vs HGH (somatropin): differences, evidence and safetySermorelin vs HGH (somatropin) compared: how a releasing-hormone fragment and growth hormone itself differ in action, trial results, safety and legal status.Read the comparison SS-31 vs MOTS-cSS-31 vs MOTS-c: differences, evidence and safetySS-31 vs MOTS-c: two peptides aimed at the mitochondria. One is approved in the US for one rare disease, one nowhere. Studies, safety and legal status.Read the comparison Survodutide vs RetatrutideSurvodutide vs Retatrutide: differences, evidence and safetySurvodutide vs retatrutide: two experimental drugs, one acting on two hormone receptors and one on three. Trials, side effects and legal status compared.Read the comparison Survodutide vs TirzepatideSurvodutide vs Tirzepatide: differences, evidence and safetySurvodutide vs tirzepatide: an experimental phase 3 drug against an approved medicine. Hormone targets, trial results, side effects and legal status compared.Read the comparison TB-500 vs TB-4 (Thymosin β4)TB-500 vs TB-4: differences, evidence and safetyTB-500 and TB-4 differ in structure and clinical evidence. Understand which trials studied full-length thymosin beta-4 and what remains unknown for TB-500.Read the comparison Tesamorelin vs CJC-1295 (no DAC)Tesamorelin vs CJC-1295: differences, evidence and safetyTesamorelin vs CJC-1295 compared: two copies of the same brain hormone, one an approved medicine, the other with no study found. Structure, evidence and safety.Read the comparison Tesamorelin vs Somatropin (HGH 191AA)Tesamorelin vs HGH (somatropin): differences, evidence and safetyTesamorelin vs HGH (somatropin) compared: a releasing-hormone copy set against growth hormone itself, with approvals, trial results, safety and doping rules.Read the comparison Tesamorelin vs RetatrutideTesamorelin vs Retatrutide: differences, evidence and safetyTesamorelin vs retatrutide compared: an approved belly-fat medicine for adults with HIV and an unapproved triple-hormone drug, their trials, safety and status.Read the comparison Tesamorelin vs SermorelinTesamorelin vs Sermorelin: differences, evidence and safetyTesamorelin vs sermorelin compared: how the two growth hormone releasing hormone copies differ in structure, approval history, trial results and safety.Read the comparison Thymalin vs Thymosin Alpha-1Thymalin vs Thymosin Alpha-1: differences, evidence and safetyThymalin vs Thymosin Alpha-1 compared: a calf thymus extract approved in Russia and a synthetic peptide approved in Italy and China, with trials and safety.Read the comparison Tirzepatide vs RetatrutideTirzepatide vs Retatrutide: differences, evidence and safetyTirzepatide vs retatrutide: an approved medicine against an experimental drug. Their hormone targets, trial results, side effects and legal status compared.Read the comparison Tirzepatide vs SemaglutideTirzepatide vs Semaglutide: differences, evidence and safetyTirzepatide vs semaglutide: two approved prescription medicines compared on hormone targets, their two direct trials, side effects and legal status.Read the comparison

All peptides A–Z

This article is for informational purposes only and does not replace medical advice. myPeptides gives no dosing recommendations.